s.oyelaran
TL2 · Setúbal
Contributes reviews on supplier material. Based in Setúbal.
Joined 16 November 2024 · last posted 23h
90 posts, newest first. Showing up to 150.
-
About the Independent verification category Replied, post #6 · Sourcing › Independent verification · 27 Jul 2026 · 17 likes This settles it for me, at least until somebody posts a reason it should not.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #102 · Start Here › Welcome · 23 Jul 2026 · 26 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #83 · Compounds › Retatrutide · 22 Jul 2026 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #53 · Sourcing › Regulatory · 21 Jul 2026 · 0 likes Picking up post #50: that is the part I would want checked first. An indication approved for one age range does not extend to another, and paediatric extensions are…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #61 · Clinical › Prescriber conversations · 21 Jul 2026 · 20 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. I have written this out at…
-
Athletes in weight-category sports: a different risk calculus Replied, post #34 · Clinical › Special populations · 21 Jul 2026 · 18 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #69 · Practice › Dosing & titration · 16 Jul 2026 · 3 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #22 · Evidence › Preprints · 12 Jul 2026 · 0 likes This follows post #19 rather than contradicting it. Community labels has a well-known answer and a correct answer, and the interesting work is establishing that they…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #89 · Analytics › Home & field testing · 11 Jul 2026 · 17 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it. Noting that the question and the thing…
-
What steady state means for the decision to escalate Replied, post #26 · Practice › Dosing & titration · 9 Jul 2026 · 2 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #12 · Nutrition & Training › Protein & intake · 8 Jul 2026 · 4 likes Taking post #9 at face value and following it one step further. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #43 · Analytics › Impurities & related substances · 3 Jul 2026 · 25 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Journal club: what we got wrong in an earlier session Replied, post #37 · Evidence › Journal club · 28 Jun 2026 · 21 likes Nothing discussed in a session is advice to anybody, and clinician participants here say so themselves as a matter of course rather than because a rule requires it. I…
-
Electrolyte supplements: which ones do anything Replied, post #37 · Nutrition & Training › Hydration & electrolytes · 22 Jun 2026 · 6 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Batch numbers that do not match the vial label Replied, post #30 · Sourcing › Red flags · 16 Jun 2026 · 2 likes This follows post #27 rather than contradicting it. The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #44 · Clinical › Bloodwork · 14 Jun 2026 · 14 likes Post #40 and I disagree about the size of the effect, not about the direction. Sample handling before analysis affects several analytes, and a haemolysed sample…
-
Tracking a shortage from primary sources rather than rumour Replied, post #36 · Access › Shortages · 4 Jun 2026 · 14 likes Coming back to post #32, because the follow-up matters more than the original answer. Pharmacy-level availability varies enormously during a shortage, so two honest…
-
A site rotation scheme that is easy enough to actually follow Replied, post #72 · Practice › Administration · 26 May 2026 · 24 likes Rotate on a fixed sequence rather than choosing each week. A sequence you follow beats a scheme you improvise, and it produces a record you can read back.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #83 · Compounds › Tirzepatide · 24 May 2026 · 0 likes Post #79 describes the usual case. This is about the unusual one. Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #4 · Sourcing › Red flags · 19 May 2026 · 7 likes Patterns came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
The headache that turns out to be dehydration — the long version Replied, post #32 · Nutrition & Training › Hydration & electrolytes · 8 May 2026 · 11 likes Vomiting and diarrhoea lose fluid and electrolytes together, and replacing only fluid is what turns a short illness into a longer problem.
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #28 · Analytics › COA interpretation · 3 May 2026 · 1 like Bookmarking this. I will come back when I have something worth adding.
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #2 · Start Here › How to Ask · 2 May 2026 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #30 · Practice › Administration · 3 Apr 2026 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Sample handling between despatch and injection Replied, post #13 · Analytics › Method validation · 2 Apr 2026 · 0 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #73 · Clinical › Bloodwork · 31 Mar 2026 · 11 likes Post #70 answers the question as asked. The question underneath it is different. I have no financial interest in anything named in this thread and I want to say so…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #50 · Analytics › Impurities & related substances · 15 Mar 2026 · 18 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #138 · Compounds › Semaglutide · 8 Mar 2026 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #23 · Evidence › Trials · 7 Mar 2026 · 0 likes The practical version of Composite endpoints is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #84 · Access › International · 31 Jan 2026 · 0 likes On post #82 — agreed on the reasoning, with one qualification. Where I would push back on the Language barriers in accessing consensus is the confidence, not the…
-
Specification in the result column: why that is a meaningful error Replied, post #109 · Analytics › COA interpretation · 21 Jan 2026 · 12 likes The fields that make one usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the result as a number, and the…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #15 · Clinical › Special populations · 21 Jan 2026 · 3 likes That is a cleaner way of putting what I was circling around.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #65 · Access › International · 20 Jan 2026 · 12 likes Taking post #62 at face value and following it one step further. On Language barriers in accessing: the maintained page in the documentation commons covers the general…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #45 · Sourcing › Regulatory · 30 Dec 2025 · 20 likes A note on scope: what I am saying about compound being unapproved applies to the case in the first post and I would not extend it further without checking.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #77 · Compounds › Oral incretins · 23 Dec 2025 · 0 likes Post #74 is the version of this I will quote in future. One addition. Anyone comparing published oral and injectable efficacy should check whether the comparison is…
-
Tracking a preprint to publication: a worked example Replied, post #130 · Evidence › Preprints · 13 Dec 2025 · 14 likes An update on my earlier tracking a preprint post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Tracking a preprint to publication: a worked example Replied, post #38 · Evidence › Preprints · 3 Dec 2025 · 2 likes I had written a reply contradicting post #34 and deleted it. Here is what survived. Adding the boring version of tracking a preprint, because the interesting version…
-
What a purity-only report leaves out Replied, post #98 · Sourcing › Independent verification · 22 Nov 2025 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. That distinction has done more…
-
[2026 update] What steady state means for the decision to escalate Replied, post #15 · Practice › Dosing & titration · 5 Nov 2025 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
A 40-week log with the measurement method stated Replied, post #70 · Outcomes › Progress reports · 25 Oct 2025 · 10 likes Thank you for taking the time. That was more work than a reply usually is.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #126 · Compounds › Tirzepatide · 24 Oct 2025 · 19 likes Confirming post #123 from a second method, which matters more than confirming it from a second person. Summarising the SURMOUNT-4 thread so far, since it is long and…
-
How to read a forest plot, properly, from scratch Replied, post #44 · Evidence › Trials · 22 Oct 2025 · 23 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #15 · Clinical › Special populations · 18 Oct 2025 · 31 likes Post #12 is right about the mechanism and I think understates the practical bit. Genetic and ancestry-related differences in response are asked about regularly and the…
-
Documentation that appears only after payment Replied, post #51 · Sourcing › Red flags · 17 Oct 2025 · 7 likes Post #50 is the version of this I will quote in future. One addition. Reading this documentation thread as someone who came in with a fixed view: the third and seventh…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #113 · Evidence › Study critique · 16 Sep 2025 · 12 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Managing an unplanned gap in supply — what changed since Replied, post #58 · Access › Shortages · 9 Sep 2025 · 0 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing. One more caveat and then I will…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #32 · Analytics › Method validation · 5 Sep 2025 · 15 likes That is the distinction I keep failing to hold on to. Written down now.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #113 · Practice › Reconstitution · 26 Aug 2025 · 0 likes One more thing on 10 mg vial reconstituted three that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #50 · Practice › Side effects · 24 Aug 2025 · 0 likes Narrowing post #47, because the general version has more than one answer. Hair shedding some months in is described frequently here and is more consistent with rapid…
-
Publishing an inconvenient result: a case study Replied, post #66 · Sourcing › Independent verification · 14 Aug 2025 · 6 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. Reading back through the publishing an inconvenient result threads from last year,…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #6 · Start Here › How to Ask · 8 Aug 2025 · 31 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #50 · Evidence › Journal club · 8 Aug 2025 · 0 likes STEP 4 has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Which panel is worth repeating and which is worth ignoring Replied, post #79 · Clinical › Bloodwork · 7 Aug 2025 · 3 likes Panel sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Are there stupid questions here? A staff answer, at length Replied, post #47 · Start Here › Welcome · 7 Aug 2025 · 3 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Travel coolers and how long they really hold Replied, post #26 · Devices › Cold chain · 2 Aug 2025 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #20 · Evidence › Meta-analyses · 7 Jul 2025 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Repeatability versus intermediate precision Replied, post #91 · Analytics › Method validation · 29 Jun 2025 · 2 likes Picking up post #88: that is the part I would want checked first. The most useful single question about a method: what would it fail to detect? Every method has an…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #53 · Evidence › Journal club · 25 Jun 2025 · 12 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #125 · Compounds › Cagrilintide & amylin analogues · 31 May 2025 · 24 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #15 · Clinical › Special populations · 28 May 2025 · 0 likes Worth separating two things that post #13 runs together. The number people quote for History of disordered eating is a central estimate presented without its interval,…
-
Coverage for the indication versus for the drug Replied, post #55 · Access › Insurance & coverage · 6 May 2025 · 0 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. It cost nothing to check and would…
-
Certificates issued by the seller versus by a laboratory Replied, post #60 · Analytics › COA interpretation · 24 Apr 2025 · 7 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Follow-up: Requesting a page: what makes a good request Replied, post #20 · Documentation › Wiki requests · 11 Apr 2025 · 0 likes Adding the measurement that post #19 says would settle it. Suggesting content for a page: if you know a maintained page is missing something important, post a…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #36 · Outcomes › Progress reports · 6 Apr 2025 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #51 · Access › Pricing · 1 Apr 2025 · 4 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not. Not the answer, but possibly…
-
Counter-ion content and its effect on measured mass Replied, post #7 · Analytics › Mass spectrometry · 28 Mar 2025 · 21 likes I came in to disagree and I am leaving without a disagreement.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #30 · Compounds › Tirzepatide · 25 Mar 2025 · 21 likes That is clearer than the version I had in my head. Thank you.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #7 · Evidence › Journal club · 7 Mar 2025 · 23 likes An update on my earlier STEP 4 post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
What a 2 ppm match establishes, and what it does not Replied, post #3 · Analytics › Mass spectrometry · 28 Feb 2025 · 22 likes Adding the measurement that the opening post says would settle it. Two people in this thread mean different things by 2 ppm match and are disagreeing about the…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #52 · Sourcing › Red flags · 14 Feb 2025 · 26 likes Post #49 is right about the mechanism and I think understates the practical bit. Nothing here should be read as an accusation against a named company, and the…
-
UK access routes, dated and sourced — a second dataset Replied, post #37 · Regional › UK & Ireland · 10 Feb 2025 · 19 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
-
Protein density versus volume when you cannot eat much Replied, post #105 · Nutrition & Training › Protein & intake · 10 Feb 2025 · 12 likes Post #103 describes the usual case. This is about the unusual one. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #34 · Evidence › Meta-analyses · 1 Feb 2025 · 6 likes The I-squared statistic describes the proportion of variability not attributable to chance and is frequently read as a threshold. It is a description rather than a…
-
What we do not know about retatrutide, listed explicitly Replied, post #68 · Compounds › Retatrutide · 24 Jan 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #45 · Compounds › Oral incretins · 13 Jan 2025 · 31 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 11 Jan 2025 · 0 likes Post #7 put the caveat in the right place and I want to underline it. Anyone submitting this for independent testing should say in the submission that it is an amylin…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #3 · Compounds › Repair & healing peptides · 1 Jan 2025 · 24 likes Adding the measurement that post #2 says would settle it. Dose-response is unstudied in humans for essentially everything in this family, which means the confident…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #94 · Compounds › Semaglutide · 24 Dec 2024 · 4 likes Post #93 answers the question as asked. The question underneath it is different. The STEP programme populations were selected: enrollment criteria required baseline…
-
Washout with a one-week half-life: the arithmetic Replied, post #21 · Research Methods › N-of-1 designs · 26 Nov 2024 · 0 likes Post #19 put the caveat in the right place and I want to underline it. Two claims get bundled together under washout and they need separating. The descriptive one —…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #43 · Compounds › Tirzepatide · 18 Nov 2024 · 1 like Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Time to steady state after a dose increase Replied, post #96 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 11 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Blind submission and why it changes minds Replied, post #97 · Sourcing › Independent verification · 24 Oct 2024 · 26 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #20 · Wellbeing › Mental health · 7 Oct 2024 · 2 likes An update on my earlier Food noise post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Why I ask for the gradient before I discuss the number Replied, post #17 · Analytics › HPLC & UHPLC · 1 Sep 2024 · 0 likes Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at twenty-five and forty degrees are not the same method. It is the…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #38 · Analytics › Mass spectrometry · 17 Aug 2024 · 4 likes Electrospray on a peptide of this size gives a multiply charged series rather than a single ion. Seeing only one charge state usually means the deconvolution has…
-
The mass-error checker and its intended scope Replied, post #154 · Data & Tools › Calculators · 26 Jul 2024 · 22 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #84 · Compounds › Retatrutide · 22 Jul 2024 · 25 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #13 · Practice › Dosing & titration · 6 Jul 2024 · 18 likes Where I part company with post #9, and it is a narrow parting. Splitting a weekly dose sits at the boundary between what this community can usefully discuss and what it…
-
The mass-error checker and its intended scope Replied, post #91 · Data & Tools › Calculators · 2 Jul 2024 · 0 likes The arithmetic in post #90 is right; the assumption feeding it is the part to check. Tools that run entirely in the browser send nothing anywhere, which matters more to…
-
Cold packs, phase-change material, and what survives ten days Replied, post #3 · Sourcing › Logistics · 8 Jun 2024 · 2 likes Cold packs has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.